Specificity of EIA immunoassay for complement factor Bb testing

Clinical Laboratory

Volumn 57, Issue 3-4, 2011, Pages 225-228

  Pavlov, Igor Y ^a   De Forest, Nikol ^b   Delgado, Julio C ^a  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b Quidel Corporation   (United States)

Author keywords

Alternative pathway activation; Complement factor Bb; Immunoassay

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT FACTOR BB; EDETIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; COMPLEMENT ACTIVATION; CROSS REACTION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNODIFFUSION; MALE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; COMPLEMENT ALTERNATIVE PATHWAY; IMMUNOASSAY;

COMPLEMENT FACTOR B; COMPLEMENT PATHWAY, ALTERNATIVE; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 79957816900     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Pangburn M. K. 1988. Alternative pathway of complement. Methods Enzymol 162:639-53. (Pubitemid 19019538)
2. nd revised ed., Springer-Verlag, New York.
3. Thurman J. M., Holers V. M. 2006. The central role of the alternative complement pathway in human disease. J Immunol 176: 1305-10.
4. Kolb W. P., Morrow P. R., Tamerius J. D. 1989. Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement Inflamm 6:175-204. (Pubitemid 19177021)
5. Hourcade D.E., Mitchell L.M., Oglesby T.J. 1998. A Conserved Element in the Serine Protease Domain of Complement Factor B. JBC 273: 25996-6000. (Pubitemid 28475832)
6. Kobayashi E., Kitano E., Kondo H., Kitamura H.. 1999. [Complement activation in citrate plasma-inhibitory effect of anticoagulants on serum complement activation]. Rinsho Byori 47: 160-4.
7. Mollnes T. E., Garred P., Bergseth G. 1988. Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. Clin Exp Immunol 73: 484-8.
8. Pfeifer P. H., Kawahara M. S., Hugli T. E. 1999. Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation. Clin Chem 45:1190-9. (Pubitemid 29424257)